Abstract:Introduction
There are no guidelines regarding management of failed pediatric renal transplants.
Materials & Methods
We performed a first of its kind multicenter study assessing prevalence of transplant nephrectomy, patient characteristics, and outcomes in pediatric renal transplant recipients with graft failure from January 1, 2006, to December 31, 2016.
Results
Fourteen centers contributed data on 186 pediatric recipients with failed transplants. The 76 recipients that underwent transplant nephrectomy were n… Show more
“…There is no apparent benefit to graft nephrectomy related to sensitization, but timing and frequency of immunosuppression withdrawal is significantly different with slightly increased risk for rejection following re-transplant. 73 In addition to these measures, individuals with a failing allograft need to be relisted as soon as their GFR will allow, to minimize time on the wait list and therefore their time on dialysis, if a preemptive transplant is not possible.…”
Section: Pre Venti On Of S En S Itiz Ati Onmentioning
confidence: 99%
“…Following transplant nephrectomy, recipients were significantly more likely to have rejection after re‐transplant (18% vs. 7%; p = .03) and multiple rejections in the first year after re‐transplant (7% vs. 1%; p = .03). There is no apparent benefit to graft nephrectomy related to sensitization, but timing and frequency of immunosuppression withdrawal is significantly different with slightly increased risk for rejection following re‐transplant 73 …”
Kidney transplantation is the treatment of choice for patients with ESRD as it is associated with improved patient survival and better quality of life, especially in children. There are several barriers to a successful transplant including organ shortage, anatomic barriers, and immunologic barriers. One of the biggest immunologic barriers that precludes transplantation is sensitization, when patients have antibodies prior to transplantation, resulting in positive crossmatches with donor. 30%–40% of adult patients on the wait list are sensitized. There is a growing number of pediatric patients on the wait list who are sensitized. This poses a unique challenge to the pediatric transplant community. Therefore, attempts to perform desensitization to remove or suppress pathogenic HLA antibodies resulting in acceptable crossmatches, and ultimately a successful transplant, while reducing the risk of acute rejection, are much needed in these children. This review article aims to address the management of such patients both prior to transplantation, with strategies to overcome sensitization, and after transplantation with monitoring for allograft rejection and other complications.
“…There is no apparent benefit to graft nephrectomy related to sensitization, but timing and frequency of immunosuppression withdrawal is significantly different with slightly increased risk for rejection following re-transplant. 73 In addition to these measures, individuals with a failing allograft need to be relisted as soon as their GFR will allow, to minimize time on the wait list and therefore their time on dialysis, if a preemptive transplant is not possible.…”
Section: Pre Venti On Of S En S Itiz Ati Onmentioning
confidence: 99%
“…Following transplant nephrectomy, recipients were significantly more likely to have rejection after re‐transplant (18% vs. 7%; p = .03) and multiple rejections in the first year after re‐transplant (7% vs. 1%; p = .03). There is no apparent benefit to graft nephrectomy related to sensitization, but timing and frequency of immunosuppression withdrawal is significantly different with slightly increased risk for rejection following re‐transplant 73 …”
Kidney transplantation is the treatment of choice for patients with ESRD as it is associated with improved patient survival and better quality of life, especially in children. There are several barriers to a successful transplant including organ shortage, anatomic barriers, and immunologic barriers. One of the biggest immunologic barriers that precludes transplantation is sensitization, when patients have antibodies prior to transplantation, resulting in positive crossmatches with donor. 30%–40% of adult patients on the wait list are sensitized. There is a growing number of pediatric patients on the wait list who are sensitized. This poses a unique challenge to the pediatric transplant community. Therefore, attempts to perform desensitization to remove or suppress pathogenic HLA antibodies resulting in acceptable crossmatches, and ultimately a successful transplant, while reducing the risk of acute rejection, are much needed in these children. This review article aims to address the management of such patients both prior to transplantation, with strategies to overcome sensitization, and after transplantation with monitoring for allograft rejection and other complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.